XML 54 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2015
Jun. 30, 2014
Stock based compensation by job function [Line Items]        
Common Shares Available for Grant 28,100   28,100  
Compensation expense related to the company's stock-based compensation plans $ 28.6 $ 29.5 $ 61.7 $ 65.1
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items]        
Stock-based compensation expense related to stock options, SAR and ESPP grants 11.7 11.7 23.3 23.7
Lease And Well [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 10.5 9.1 22.6 20.7
Gathering And Processing Costs [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 0.3 0.2 0.6 0.5
Exploration Costs [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans 5.9 5.6 13.3 13.5
General And Administrative [Member]        
Stock based compensation by job function [Line Items]        
Compensation expense related to the company's stock-based compensation plans $ 11.9 $ 14.6 $ 25.2 $ 30.4
Stock Options and SARs [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 29.78 $ 27.68
Expected Volatility (in hundredths)     38.93% 35.15%
Risk-Free Interest Rate (in hundredths)     0.82% 0.86%
Dividend Yield (in hundredths)     0.73% 0.50%
Expected Life (in years)     5 years 3 months 18 days 5 years 2 months 12 days
Stock Options and SARs Rollforward [Abstract]        
Outstanding at January 1 (in shares)     10,493 10,452
Granted (in shares)     39 74
Exercised (1) (in shares) [1]     (885) (922)
Forfeited (in shares)     (177) (185)
Outstanding at June 30 (2) (in shares) [2] 9,470 9,419 9,470 9,419
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Outstanding at January 1 (price per share)     $ 64.96 $ 54.43
Granted (price per share)     92.37 92.51
Exercised (1) (price per share) [1]     48.30 43.76
Forfeited (price per share)     79.43 62.02
Outstanding at June 30 (2) (price per share) [2] $ 66.36 $ 55.62 $ 66.36 $ 55.62
Stock Options and SARs Vested or Expected to Vest (in shares) [3] 8,987 8,985 8,987 8,985
Weighted average grant price for stock options/SARs vested or expected to vest (price per share) [3] $ 65.56 $ 55.22 $ 65.56 $ 55.22
Stock Options and SARs Exercisable at June 30 (in shares) [4] 4,635 3,898 4,635 3,898
Stock Options and SARs Exercisable at June 30 (price per share) [4] $ 50.92 $ 44.71 $ 50.92 $ 44.71
Intrinsic value of stock options/SARs exercised during the period [1]     $ 39.1 $ 52.5
Aggregate intrinsic value for outstanding stock options and SARs [2] $ 229.5 $ 576.8 $ 229.5 $ 576.8
Weighted average remaining contractual life for stock options/SARs outstanding (in years)     3 years 10 months 24 days 4 years 2 months 12 days
Aggregate intrinsic value of stock options/SARs vested or expected to vest [3] 223.6 553.8 $ 223.6 $ 553.8
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)     3 years 10 months 24 days 4 years 2 months 12 days
Aggregate intrinsic value for exercisable units [4] 170.9 281.3 $ 170.9 $ 281.3
Weighted average remaining contractual life for exercisable options/SARs (in years)     2 years 7 months 6 days 2 years 9 months 18 days
Unrecognized compensation expense 87.1   $ 87.1  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 2 months 12 days  
ESPP [Member]        
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract]        
Weighted Average Fair Value of Grants (price per share)     $ 23.39 $ 18.30
Expected Volatility (in hundredths)     37.47% 25.83%
Risk-Free Interest Rate (in hundredths)     0.11% 0.09%
Dividend Yield (in hundredths)     0.72% 0.40%
Expected Life (in years)     6 months 6 months
Restricted Stock and Restricted Stock Units [Member]        
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Unrecognized compensation expense 171.7   $ 171.7  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     2 years 4 months 24 days  
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost $ 16.5 $ 16.8 $ 37.7 $ 39.5
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]        
Outstanding at January 1 (in shares)     5,394 7,358
Granted (in shares)     456 435
Released (in shares) [5]     (593) (1,939)
Forfeited (in shares)     (130) (181)
Outstanding at June 30 (1) (in shares) [6] 5,127 5,673 5,127 5,673
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]        
Outstanding at January 1 (price per share)     $ 64.39 $ 49.54
Granted (price per share)     88.29 94.73
Released (price per share) [5]     54.85 36.85
Forfeited (price per share)     74.13 58.48
Outstanding at June 30 (1) (price per share) [6] $ 67.37 $ 57.06 $ 67.37 $ 57.06
Intrinsic value of restricted stock and restricted stock units released during the year [5]     $ 53.9 $ 207.0
Aggregate intrinsic value of stock and units outstanding [6] $ 448.9 $ 662.9 448.9 $ 662.9
Performance Units and Performance Stock [Member]        
Share-Based Compensation Arrangement By Share Based Payment Award Stock Option/SARs, ESPP, Restricted Stock/Units and Performance Units/Stock [Abstract]        
Unrecognized compensation expense $ 4.7   $ 4.7  
Weighted average period over which unrecognized compensation expense will be recognized (in years)     3 years  
Restricted Stock/Restricted Stock Units and Performance Units/Performance Stock [Roll Forward]        
Outstanding at January 1 (in shares)     333 261
Granted (in shares)     0 0
Released (in shares)     0 0
Forfeited (in shares)     0 0
Outstanding at June 30 (1) (in shares) [7] 333 261 333 261
Weighted Average Grant Price Restricted Stock and Restricted Stock Units/Performance Units and Performance Stock [Roll Forward]        
Outstanding at January 1 (price per share)     $ 90.17 $ 82.18
Granted (price per share)     0.00 0.00
Released (price per share)     0.00 0.00
Forfeited (price per share)     0.00 0.00
Outstanding at June 30 (1) (price per share) [7] $ 90.17 $ 82.18 $ 90.17 $ 82.18
Aggregate intrinsic value of stock and units outstanding [7] $ 29.2 $ 30.5 $ 29.2 $ 30.5
Performance Units and Performance Stock [Abstract]        
Share-Based Compensation Arrangement By Performance Units and Performance Stock Compensation Cost $ 0.4 $ 1.0 $ 0.7 $ 1.9
[1] The total intrinsic value of stock options/SARs exercised for the six months ended June 30, 2015 and 2014 was $39.1 million and $52.5 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs.
[2] The total intrinsic value of stock options/SARs outstanding at June 30, 2015 and 2014 was $229.5 million and $576.8 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 3.9 years and 4.2 years, respectively.
[3] The total intrinsic value of stock options/SARs vested or expected to vest at June 30, 2015 and 2014 was $223.6 million and $553.8 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 3.9 years and 4.2 years, respectively.
[4] The total intrinsic value of stock options/SARs exercisable at June 30, 2015 and 2014 was $170.9 million and $281.3 million, respectively. At June 30, 2015 and 2014, the weighted average remaining contractual life was 2.6 years and 2.8 years, respectively.
[5] The total intrinsic value of restricted stock and restricted stock units released for the six months ended June 30, 2015 and 2014 was $53.9 million and $207.0 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released.
[6] The total intrinsic value of restricted stock and restricted stock units outstanding at June 30, 2015 and 2014 was $448.9 million and $662.9 million, respectively.
[7] The total intrinsic value of performance units and performance stock outstanding at June 30, 2015 and 2014 was $29.2 million and $30.5 million, respectively.